RADIOGARDASE

This brand name is authorized in United States. It is also authorized in France, Japan.

Active ingredients

The drug RADIOGARDASE contains one active pharmaceutical ingredient (API):

1
UNII TLE294X33A - FERRIC FERROCYANIDE
 

Prussian blue insoluble binds cesium and thallium isotopes in the gastrointestinal tract after these isotopes are ingested or excreted in the bile by the liver, thereby reducing gastrointestinal reabsorption (enterohepatic circulation).

 
Read more about Prussian blue

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 RADIOGARDASE Capsule MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB31 Prussian blue V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB31

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 65903335
JP 医薬品医療機器総合機構 392900XM1028
US FDA, National Drug Code 58060-002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.